Tag Archives: chris ward

Guest column : Can Indian generics move from blockbusters to biologics?

20 Jun

For generic dug manufacturers in India and elsewhere the number of blockbuster drugs that have recently come off patent has been a bonanza. But the product mix coming off patent over the next three years is dramatically different to the small molecule blockbuster drugs that dominated patent expirations in 2012. This presents a problem for them. Continue reading

Guest column : Is Indian Pharma’s spectacular growth Bonanza or Bubble?

12 Jun

Indian pharmaceutical companies’ profits have grown hugely in recent years. Contrary to claims that India’s robust generics industry is driven by being ‘the drug store for the developing world’, overwhelmingly the growth of the industry is from sales to established country markets in the US and Europe. But predictions for continued growth may prove to be optimistic. Continue reading

%d bloggers like this: